BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21567396)

  • 1. HIV-1 Nef perturbs the function, structure, and signaling of the Golgi through the Src kinase Hck.
    Hiyoshi M; Takahashi-Makise N; Yoshidomi Y; Chutiwitoonchai N; Chihara T; Okada M; Nakamura N; Okada S; Suzu S
    J Cell Physiol; 2012 Mar; 227(3):1090-7. PubMed ID: 21567396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dys-regulated activation of a Src tyroine kinase Hck at the Golgi disturbs N-glycosylation of a cytokine receptor Fms.
    Hassan R; Suzu S; Hiyoshi M; Takahashi-Makise N; Ueno T; Agatsuma T; Akari H; Komano J; Takebe Y; Motoyoshi K; Okada S
    J Cell Physiol; 2009 Nov; 221(2):458-68. PubMed ID: 19585521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between Hck and HIV-1 Nef negatively regulates cell surface expression of M-CSF receptor.
    Hiyoshi M; Suzu S; Yoshidomi Y; Hassan R; Harada H; Sakashita N; Akari H; Motoyoshi K; Okada S
    Blood; 2008 Jan; 111(1):243-50. PubMed ID: 17893228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase.
    Choi HJ; Smithgall TE
    J Mol Biol; 2004 Nov; 343(5):1255-68. PubMed ID: 15491611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomerization is required for HIV-1 Nef-induced activation of the Src family protein-tyrosine kinase, Hck.
    Ye H; Choi HJ; Poe J; Smithgall TE
    Biochemistry; 2004 Dec; 43(50):15775-84. PubMed ID: 15595833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of activator protein 1 (AP-1) in macrophages by human immunodeficiency virus type-1 NEF is a cell-type-specific response that requires both hck and MAPK signaling events.
    Biggs TE; Cooke SJ; Barton CH; Harris MP; Saksela K; Mann DA
    J Mol Biol; 1999 Jul; 290(1):21-35. PubMed ID: 10388555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Nef interferes with M-CSF receptor signaling through Hck activation and inhibits M-CSF bioactivities.
    Suzu S; Harada H; Matsumoto T; Okada S
    Blood; 2005 Apr; 105(8):3230-7. PubMed ID: 15626739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
    Dutartre H; Harris M; Olive D; Collette Y
    Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Nef triggers macrophage fusion in a p61Hck- and protease-dependent manner.
    Vérollet C; Zhang YM; Le Cabec V; Mazzolini J; Charrière G; Labrousse A; Bouchet J; Medina I; Biessen E; Niedergang F; Bénichou S; Maridonneau-Parini I
    J Immunol; 2010 Jun; 184(12):7030-9. PubMed ID: 20488787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nef proteins of distinct HIV-1 or -2 isolates differ in their binding properties for HCK: isolation of a novel Nef binding factor with characteristics of an adaptor protein.
    Karn T; Hock B; Holtrich U; Adamski M; Strebhardt K; Rübsamen-Waigmann H
    Virology; 1998 Jun; 246(1):45-52. PubMed ID: 9656992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction with the Src homology (SH3-SH2) region of the Src-family kinase Hck structures the HIV-1 Nef dimer for kinase activation and effector recruitment.
    Alvarado JJ; Tarafdar S; Yeh JI; Smithgall TE
    J Biol Chem; 2014 Oct; 289(41):28539-53. PubMed ID: 25122770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Nef Induces Hck/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17/G-CSF Levels.
    Priceputu E; Cool M; Bouchard N; Caceres-Cortes JR; Lowell CA; Hanna Z; Jolicoeur P
    J Virol; 2021 Aug; 95(17):e0047121. PubMed ID: 34106001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
    Lerner EC; Smithgall TE
    Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 proteins preferentially activate anti-inflammatory M2-type macrophages.
    Chihara T; Hashimoto M; Osman A; Hiyoshi-Yoshidomi Y; Suzu I; Chutiwitoonchai N; Hiyoshi M; Okada S; Suzu S
    J Immunol; 2012 Apr; 188(8):3620-7. PubMed ID: 22407921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Nef-Induced Secretion of the Proinflammatory Protease TACE into Extracellular Vesicles Is Mediated by Raf-1 and Can Be Suppressed by Clinical Protein Kinase Inhibitors.
    Zhao Z; Fagerlund R; Baur AS; Saksela K
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtle Dynamic Changes Accompany Hck Activation by HIV-1 Nef and are Reversed by an Antiretroviral Kinase Inhibitor.
    Wales TE; Hochrein JM; Morgan CR; Emert-Sedlak LA; Smithgall TE; Engen JR
    Biochemistry; 2015 Oct; 54(41):6382-91. PubMed ID: 26440750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribotoxic stress response to the trichothecene deoxynivalenol in the macrophage involves the SRC family kinase Hck.
    Zhou HR; Jia Q; Pestka JJ
    Toxicol Sci; 2005 Jun; 85(2):916-26. PubMed ID: 15772366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Nef induces p47(phox) phosphorylation leading to a rapid superoxide anion release from the U937 human monoblastic cell line.
    Olivetta E; Mallozzi C; Ruggieri V; Pietraforte D; Federico M; Sanchez M
    J Cell Biochem; 2009 Apr; 106(5):812-22. PubMed ID: 19130504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular kinase binding motifs (PxxP and RR) in human immunodeficiency virus type 1 Nef protein are dispensable for producer-cell-dependent enhancement of viral entry.
    Tokunaga K; Ikuta K; Adachi A; Matsuda M; Kurata T; Kojima A
    Virology; 1999 May; 257(2):285-9. PubMed ID: 10329538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.